Mehmet Asim Bilen Sumit K Subudhi Jianjun Gao Nizar M Tannir Shi-Ming Tu Padmanee Sharma
10.1186/s40425-016-0139-8
J Immunother Cancer
2016 Jun 21;4:36.
immune checkpoint inhibitors immune-related adverse event ipilimumab nivolumab polymyositis rhabdomyolysis urothelial carcinoma
CC BY
https://pubmed.ncbi.nlm.nih.gov/27330809/
PMC4915058
27330809
Acute rhabdomyolysis with severe polymyositis following ipilimumab-nivolumab treatment in a cancer patient with elevated anti-striated muscle antibody
2016